Literature DB >> 16520406

Noninvasive hemodynamic measurements: an important advance in individualizing drug therapies for hypertensive patients.

John M Flack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16520406     DOI： 10.1161/01.HYP.0000209579.56979.a0

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  4 in total

1.  Who benefits more from hemodynamically guided hypotensive therapy? The experience from two randomized, prospective and controlled trials.

Authors:  Paweł Krzesiński; Grzegorz Gielerak; Adam Stańczyk; Katarzyna Piotrowicz; Andrzej Skrobowski
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-12-02

Review 2.  Integrated Genomic Medicine: A Paradigm for Rare Diseases and Beyond.

Authors:  N J Schork; K Nazor
Journal:  Adv Genet       Date:  2017-07-25       Impact factor: 1.944

3.  Relationship of resistant hypertension and treatment outcomes with total arterial compliance in a predominantly African American hypertensive cohort.

Authors:  Omid Bakhtar; Brian A Ference; Lowell A Hedquist; Phillip D Levy; John M Flack
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-18       Impact factor: 3.738

4.  A "patient-tailored" treatment of hypertension with use of impedance cardiography: a randomized, prospective and controlled trial.

Authors:  Paweł Krzesiński; Grzegorz Gerard Gielerak; Jarosław Józef Kowal
Journal:  Med Sci Monit       Date:  2013-04-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.